Skip to Page Content
Warning Message New York is unable to fulfill requests at this time. The VRDBS is compliant with regulations mandated by H.R. 1281.
Skip to Page Content

Frequently Asked Questions (FAQ)

About Newborn Screening and Research

  • What are newborn screening (NBS) specimens?
  • How are newborn screening (NBS) specimens used after screening is completed?
  • How are dried blood spot specimens (DBS) collected?
  • How are specimens stored in each state?
  • Can I identify the individual from whom the specimen was obtained?
  • Where can I find more information about newborn screening (NBS) and research?

About the VRDBS

  • Who can request specimens from the VRDBS?
  • What obligations do I have as a researcher to protect the privacy of specimens?
  • Is the VRDBS a covered entity subject to HIPAA regulations?
  • Are the data in the VRDBS HIPAA compliant?
  • Why is a state not listed as a participant in the VRDBS?
  • What demographic data is available in the VRDBS?
  • How are "Diagnosed Conditions" determined in the VRDBS?
  • How do NBSTRN and the states' newborn screening (NBS) programs determine how much specimen to send?
  • How do I know when dried blood spots are no longer available?
  • What is the proper acknowledgement to use when publishing my published research?

About the VRDBS Request Process

  • What is required to request specimens?
  • How long will it take to get my request approved?
  • How much will the specimen sharing process cost and why is there variation from state to state?
  • How soon will I receive the requested specimens?
  • Do I need Institutional Review Board (IRB) review to obtain specimens?
  • Will I need to return unused specimens?
  • Are Material Transfer Agreements required?
  • In addition to IRB approval and a Material Transfer Agreement will I need to submit any additional information?
  • Are there state specific requirements to consent for my research?